ULBI
Ultralife Corporation
NASDAQ · Industrials · Electrical Equipment & Parts · US
$6.13
+0.49%Year over year
Reported trailing growth
- Revenue
- +4.7%
- EBITDA
- —
- EBIT
- -34.1%
- EPS
- —
- Free cash flow
- -85.4%
- Operating cash flow
- -70.0%
Forward estimates
Based on analyst estimates
- Revenue
- -37.2%
- EBITDA
- +2690.5%
- EPS
- +224.9%
Three-year CAGR
- Revenue
- +13.2%
- EBITDA
- -40.3%
- EBIT
- +315.0%
- Net income
- —
- EPS
- —
- Free cash flow
- -51.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026